Retatrutide (GIP/GLP-1/GCG Receptor Tri-Agonist) – Premium Quality API

Product Overview

Retatrutide is a single 39-amino-acid peptide backbone structurally modified to target three key metabolic pathways: GIP, GLP-1, and Glucagon receptors. As a leading molecule in next-generation metabolic and weight management research, its complex structural design demands highly sophisticated chemical synthesis and purification capabilities.

Technical Specifications & Quality Attributes

• Purity (HPLC): ≥ 99.0%

• Identity (MS): Confirmed by HPLC/MS

• Appearance: Lyophilized white to off-white powder

• Quality Control: Rigorous CQA (Critical Quality Attributes) tracking, including mass spectrometry sequencing, mass balance verification, and residual solvent control under GMP-compliant standards.

Commercial Supply & Booking Terms

• Supply Capacity: Fully capable of Kilogram-scale (kg) commercial batch production.

• Lead Time: Due to the rigorous synthesis cycles and strict quality control protocols required for large-scale batches, a 1-month advance pre-order is required.

Regulatory & Compliance Notice

Disclaimer: This product is an active pharmaceutical ingredient (API) / chemical intermediate intended solely for laboratory research, formulation development, or further manufacturing use. It is not intended for direct human therapeutic use or direct consumer distribution. All promotion and supply adhere strictly to international and domestic advertising laws regarding pharmaceutical raw materials.